(April 18 20:14) Forbes.com
Cambrium, a leading German start-up focused on applying generative AI to protein design and synthesis, has successfully completed its collaboration with Ginkgo Bioworks, a company building the leading platform for cell programming and biosecurity.
You can find the original article
here
